When Innovation Meets Compliance
Nerhapezil… The Only Donepezil (Acetylcholinesterase Inhibitor) In Egypt With ODF Technology
The Formula of Success
- Nerhapezil: The Only Donepezil (Acetylcholinesterase Inhibitor) In Egypt With ODF Technology
- Nerhapezil: Donepezil HCl has Proven Efficacy in Management of Alzheimer’s Disease.
- Nerhapezil: The Only Selective Non-Competitive Rapid Reversible ACHI for Alzheimer’s Disease Patients.
- Nerhapezil: FDA Approved for Use Across the Full Spectrum Alzheimer’s Disease (Mild – Moderate – Severe).
- Nerhapezil: Significantly Improves Cognition & Social Behavior in Alzheimer’s Disease Patients.
- Nerhapezil: The Highest Tolerability with The Least Side Effects Among Other Acetylcholinesterase Inhibitors Prescribed for Alzheimer’s Disease.
- Nerhapezil: For the Best Patient’s Compliance :
- Easier Intake & Administration.
- Smarter Route of Administration.
- Greater Patient Adherence to Therapy.
Indications
NERHAPEZILis indicated for the symptomatic treatment of mild to moderately sever Alzheimer’s dementia ”
Dosage & administration
Dosage & administration
Once daily at bedtime.